(3S)-2-[(((3-Amino-3-carboxy)propyl)(hydroxy)phosphinyl)-methyl]butan-1,4-dioic Acid

ID: ALA1092315

PubChem CID: 24779945

Max Phase: Preclinical

Molecular Formula: C9H16NO8P

Molecular Weight: 297.20

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@@H](CCP(=O)(O)CC(CC(=O)O)C(=O)O)C(=O)O

Standard InChI:  InChI=1S/C9H16NO8P/c10-6(9(15)16)1-2-19(17,18)4-5(8(13)14)3-7(11)12/h5-6H,1-4,10H2,(H,11,12)(H,13,14)(H,15,16)(H,17,18)/t5?,6-/m0/s1

Standard InChI Key:  PGKLRXONCFHSCZ-GDVGLLTNSA-N

Molfile:  

     RDKit          2D

 19 18  0  0  0  0  0  0  0  0999 V2000
    5.5596  -26.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2741  -26.1066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9885  -26.5191    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    7.7030  -26.1066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9885  -27.3441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9804  -25.6896    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8451  -26.1066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1306  -26.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4162  -26.1066    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1306  -27.3441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8451  -25.2816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4174  -26.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1320  -26.1066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8464  -26.5191    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1320  -25.2816    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4174  -27.3441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1320  -27.7566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8464  -27.3441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1320  -28.5816    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  8 10  2  0
  2  3  1  0
  7 11  1  1
  3  6  2  0
  4 12  1  0
  1  2  1  0
 12 13  1  0
  1  7  1  0
 13 14  1  0
  3  4  1  0
 13 15  2  0
  7  8  1  0
 12 16  1  0
 16 17  1  0
  8  9  1  0
 17 18  1  0
  3  5  1  0
 17 19  2  0
M  END

Associated Targets(non-human)

Grm4 Metabotropic glutamate receptor 4 (663 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm6 Metabotropic glutamate receptor 6 (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm8 Metabotropic glutamate receptor 8 (169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm7 Metabotropic glutamate receptor 7 (580 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm1 Metabotropic glutamate receptor 1 (1186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm5 Metabotropic glutamate receptor 5 (4372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm2 Metabotropic glutamate receptor 2 (1326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 297.20Molecular Weight (Monoisotopic): 297.0614AlogP: -0.77#Rotatable Bonds: 9
Polar Surface Area: 175.22Molecular Species: ZWITTERIONHBA: 5HBD: 5
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.86CX Basic pKa: 9.53CX LogP: -4.20CX LogD: -11.98
Aromatic Rings: Heavy Atoms: 19QED Weighted: 0.34Np Likeness Score: 0.79

References

1. Selvam C, Oueslati N, Lemasson IA, Brabet I, Rigault D, Courtiol T, Cesarini S, Triballeau N, Bertrand HO, Goudet C, Pin JP, Acher FC..  (2010)  A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.,  53  (7): [PMID:20218620] [10.1021/jm901523t]

Source